5/27/2014 9:19:29 AM
SAN DIEGO, May 27, 2014 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced its scheduled presentations at the following investor conferences in June:
Help employers find you! Check out all the jobs and post your resume.
comments powered by